Stem cells take on Huntington's: new trial shows promise
NCT ID NCT03252535
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 33 times
Summary
This study tested a stem-cell treatment called Cellavita HD in 49 adults with Huntington's disease. Participants received one of two doses or a placebo, and researchers tracked changes in motor skills over time. The goal was to see if the therapy could slow down the worsening of movement problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUNTINGTON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Azidus Brasil Pesquisa Científica e Desenvolvimento Ltda.
Valinhos, São Paulo, 13271-130, Brazil
Conditions
Explore the condition pages connected to this study.